Study Upholds Breast Cancer Mortality For Hormone Replacement

by drsjbecker on April 16, 2013

In the nearly 11 years since researchers first rang alarm bells that women on hormone replacement therapy faced an increased risk of breast cancer, some have suggested that taking estrogen and progestin to treat symptoms of menopause might not be so dangerous after all.

Though it was generally agreed that woman who took the two hormones to curb their hot flashes and night sweats upped their chances of developing the disease, many studies suggested that the cancers the women developed were less likely to be deadly.

A new analysis of data from the Women’s Health Initiative now casts doubt on those findings. The study, published Friday by the Journal of the National Cancer Institute, concludes that the prognosis for cancers related to hormone replacement therapy is just as dire as for other breast cancers. As a result, women who turn to the treatment are more likely to die of breast cancer than their peers who don’t take hormones.

Los Angeles Times (latimes.com) – By Eryn Brown – (Saturday, March 30, 2013)

Share

{ 0 comments… add one now }

Leave a Comment

Previous post:

Next post: